This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (313) Depression and Mood Disorders; Suicide Prevention (1386) Methods and New Tools in Mental Health Research (461)

Published on in Vol 11, No 1 (2022): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30163, first published .
The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial

The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial

The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial

Authors of this article:

Yuliya Knyahnytska1 Author Orcid Image ;   Reza Zomorrodi1 Author Orcid Image ;   Tyler Kaster1 Author Orcid Image ;   Daphne Voineskos1 Author Orcid Image ;   Alisson Trevizol1 Author Orcid Image ;   Daniel Blumberger1 Author Orcid Image
Article Authors Cited by (1) Tweetations (4) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.